Imagine Lithium Aktie - ILI

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,025

Gebot

0,03

Fragen

0,03

Volumen

0,00 Tagesbereich 0,00

0,015 52-Wochen-Bereich 0,055

Marktkapitalisierung

6,928M

Handelsende

0,025

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

102.522

Ausgegebene Aktien

277.128.000

Dividendenrendite

Kurs-Gewinn-Verhältnis

8,70

Gewinn pro Aktie (EPS)

Erlöse

Nettogewinn

637k

Sektor

Miscellaneous Metal Ores,nec

Branche

Unit Inv Tr, Closed-end Mgmt

Website

www.imaginelithium.com

Hauptsitz

Vancouver, British Columbia, Can

Gegründet

2007

Imagine Lithium Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Börse with ticker ILI. The last closing price for Imagine Lithium was $0,03. Over the last year, Imagine Lithium shares have traded in a share price range of $ 0,015 to $ 0,055.

Imagine Lithium currently has 277.128.000 shares in issue. The market capitalisation of Imagine Lithium is $6,93 million. Imagine Lithium has a price to earnings ratio (PE ratio) of 8.70.

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

WALTHAM, Mass., Feb. 4 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will make a corporate...

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

WALTHAM, Mass. and MADRID, Jan. 19 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) and LABEC Pharma, S.L. announced today...

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Test Available Under Inherent Health(TM) Brand Promotes Early Action for Fracture Prevention with Recommendations for Improving Bone Health...

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

WALTHAM, Mass., Dec. 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has received approval by the...

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

New Study Published in Annals of Rheumatic Diseases Suggests IL-1 Biology Plays Central Role in Development of Severe Knee Osteoarthritis WALTHAM...

Interleukin Genetics Reports Third Quarter 2009 Financial Results

WALTHAM, Mass., Nov. 12 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) today announced financial and operational results...

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

WALTHAM, Mass., Nov. 5 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call...

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

WALTHAM, Mass. and ADA, Mich., Oct. 29 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it has entered into...

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

WALTHAM, Mass., Oct. 13 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic...

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

Subjects on Diets Appropriate for their Genotype Achieved Statistically significant Average Weight Loss of 6.2% of Body Weight at one year...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.025	0.03	0.025	23938	0.025	CS
4	0.005	25	0.02	0.03	0.015	127796	0.02215631	CS
12	0	0	0.025	0.03	0.015	102522	0.02112383	CS
26	-0.01	-28.5714285714	0.035	0.035	0.015	74679	0.02270169	CS
52	-0.01	-28.5714285714	0.035	0.055	0.015	101020	0.03176822	CS
156	-0.09	-78.2608695652	0.115	0.15	0.015	195723	0.07523265	CS
260	-0.04	-61.5384615385	0.065	0.28	0.015	297762	0.09799046	CS

ILI - Frequently Asked Questions (FAQ)

What is the current Imagine Lithium share price?

The current share price of Imagine Lithium is $ 0,025

How many Imagine Lithium shares are in issue?

Imagine Lithium has 277.128.000 shares in issue

What is the market cap of Imagine Lithium?

The market capitalisation of Imagine Lithium is CAD 6,93M

What is the 1 year trading range for Imagine Lithium share price?

Imagine Lithium has traded in the range of $ 0,015 to $ 0,055 during the past year

What is the PE ratio of Imagine Lithium?

The price to earnings ratio of Imagine Lithium is 8,7

What is the reporting currency for Imagine Lithium?

Imagine Lithium reports financial results in CAD

What is the latest annual profit for Imagine Lithium?

The latest annual profit of Imagine Lithium is CAD 637k

What is the registered address of Imagine Lithium?

The registered address for Imagine Lithium is 1240 - 789 WEST PENDER STREET, VANCOUVER, BRITISH COLUMBIA, V6C 1H2

What is the Imagine Lithium website address?

The website address for Imagine Lithium is www.imaginelithium.com

Which industry sector does Imagine Lithium operate in?

Imagine Lithium operates in the UNIT INV TR, CLOSED-END MGMT sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,095 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,095 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0
AAAAAuralite Investments Inc	$ 0,265 (0,00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0,095 (0,00%)	0
AAAlba Minerals Ltd	$ 0,03 (0,00%)	0
A.HArmor Minerals Inc	$ 0,355 (0,00%)	0
AArmor Minerals Inc	$ 0,45 (0,00%)	0

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Imagine Lithium Inc (ILI)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Imagine Lithium Inc

ILI Neueste Nachrichten

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

ILI - Frequently Asked Questions (FAQ)

Beweger

ILI Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Imagine Lithium Inc (ILI) Börsenkurse

Imagine Lithium Inc (ILI)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Imagine Lithium Inc

ILI Neueste Nachrichten

Interleukin Genetics to Present at the 12th Annual BIO CEO Conference

LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in Europe

Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone Mi

Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New York

Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis

Interleukin Genetics Reports Third Quarter 2009 Financial Results

Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results

Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests

Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings

Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss

ILI - Frequently Asked Questions (FAQ)

Beweger

ILI Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen